12-2237227-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000719.7(CACNA1C):c.477+116797C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 152,012 control chromosomes in the GnomAD database, including 10,219 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.35 ( 10219 hom., cov: 32)
Consequence
CACNA1C
NM_000719.7 intron
NM_000719.7 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.486
Publications
29 publications found
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
- Timothy syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizuresInheritance: AD Classification: STRONG Submitted by: Ambry Genetics
- long QT syndromeInheritance: AD Classification: MODERATE Submitted by: ClinGen
- long QT syndrome 8Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
- Brugada syndrome 3Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- short QT syndromeInheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-2237227-C-T is Benign according to our data. Variant chr12-2237227-C-T is described in ClinVar as Benign. ClinVar VariationId is 1168308.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.472 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1C | ENST00000399603.6 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 5 | NM_001167623.2 | ENSP00000382512.1 | |||
| CACNA1C | ENST00000399655.6 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | NM_000719.7 | ENSP00000382563.1 | |||
| CACNA1C | ENST00000682544.1 | c.567+116797C>T | intron_variant | Intron 3 of 49 | ENSP00000507184.1 | |||||
| CACNA1C | ENST00000406454.8 | c.477+116797C>T | intron_variant | Intron 3 of 47 | 5 | ENSP00000385896.3 | ||||
| CACNA1C | ENST00000399634.6 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 5 | ENSP00000382542.2 | ||||
| CACNA1C | ENST00000683824.1 | c.567+116797C>T | intron_variant | Intron 3 of 47 | ENSP00000507867.1 | |||||
| CACNA1C | ENST00000347598.9 | c.477+116797C>T | intron_variant | Intron 3 of 48 | 1 | ENSP00000266376.6 | ||||
| CACNA1C | ENST00000344100.7 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000341092.3 | ||||
| CACNA1C | ENST00000327702.12 | c.477+116797C>T | intron_variant | Intron 3 of 47 | 1 | ENSP00000329877.7 | ||||
| CACNA1C | ENST00000399617.6 | c.477+116797C>T | intron_variant | Intron 3 of 47 | 5 | ENSP00000382526.1 | ||||
| CACNA1C | ENST00000682462.1 | c.567+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000507105.1 | |||||
| CACNA1C | ENST00000683781.1 | c.567+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000507434.1 | |||||
| CACNA1C | ENST00000683840.1 | c.567+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000507612.1 | |||||
| CACNA1C | ENST00000683956.1 | c.567+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000506882.1 | |||||
| CACNA1C | ENST00000399638.5 | c.477+116797C>T | intron_variant | Intron 3 of 47 | 1 | ENSP00000382547.1 | ||||
| CACNA1C | ENST00000335762.10 | c.477+116797C>T | intron_variant | Intron 3 of 47 | 5 | ENSP00000336982.5 | ||||
| CACNA1C | ENST00000399606.5 | c.477+116797C>T | intron_variant | Intron 3 of 47 | 1 | ENSP00000382515.1 | ||||
| CACNA1C | ENST00000399621.5 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382530.1 | ||||
| CACNA1C | ENST00000399637.5 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382546.1 | ||||
| CACNA1C | ENST00000402845.7 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000385724.3 | ||||
| CACNA1C | ENST00000399629.5 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382537.1 | ||||
| CACNA1C | ENST00000682336.1 | c.477+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000507898.1 | |||||
| CACNA1C | ENST00000399591.5 | c.477+116797C>T | intron_variant | Intron 3 of 45 | 1 | ENSP00000382500.1 | ||||
| CACNA1C | ENST00000399595.5 | c.477+116797C>T | intron_variant | Intron 3 of 45 | 1 | ENSP00000382504.1 | ||||
| CACNA1C | ENST00000399649.5 | c.477+116797C>T | intron_variant | Intron 3 of 45 | 1 | ENSP00000382557.1 | ||||
| CACNA1C | ENST00000399597.5 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382506.1 | ||||
| CACNA1C | ENST00000399601.5 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382510.1 | ||||
| CACNA1C | ENST00000399641.6 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382549.1 | ||||
| CACNA1C | ENST00000399644.5 | c.477+116797C>T | intron_variant | Intron 3 of 46 | 1 | ENSP00000382552.1 | ||||
| CACNA1C | ENST00000682835.1 | c.477+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000507282.1 | |||||
| CACNA1C | ENST00000683482.1 | c.477+116797C>T | intron_variant | Intron 3 of 46 | ENSP00000507169.1 | |||||
| CACNA1C | ENST00000682686.1 | c.477+116797C>T | intron_variant | Intron 3 of 45 | ENSP00000507309.1 | |||||
| CACNA1C | ENST00000682152.1 | c.426+116797C>T | intron_variant | Intron 2 of 5 | ENSP00000506759.1 | |||||
| CACNA1C | ENST00000480911.6 | n.477+116797C>T | intron_variant | Intron 3 of 26 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.354 AC: 53760AN: 151896Hom.: 10224 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
53760
AN:
151896
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.354 AC: 53793AN: 152012Hom.: 10219 Cov.: 32 AF XY: 0.348 AC XY: 25883AN XY: 74294 show subpopulations
GnomAD4 genome
AF:
AC:
53793
AN:
152012
Hom.:
Cov.:
32
AF XY:
AC XY:
25883
AN XY:
74294
show subpopulations
African (AFR)
AF:
AC:
19793
AN:
41444
American (AMR)
AF:
AC:
4367
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
1021
AN:
3468
East Asian (EAS)
AF:
AC:
261
AN:
5172
South Asian (SAS)
AF:
AC:
1190
AN:
4816
European-Finnish (FIN)
AF:
AC:
3369
AN:
10562
Middle Eastern (MID)
AF:
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22756
AN:
67956
Other (OTH)
AF:
AC:
680
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1729
3458
5187
6916
8645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
524
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Long QT syndrome Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.